| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 456.48 | 23.1% | 27.4% |
| Total Income | 467.34 | 22.5% | 26.6% |
| Expenditure | 378.54 | 23.7% | 30.6% |
| PBT | 88.80 | 17.5% | 9.4% |
| Net Profit | 66.56 | 14.6% | 9.4% |
| OPM | 19.47% | 0.99pp | 2.85pp |
| NPM | 14.24% | 0.98pp | 2.24pp |
| EPS | 7.32 | 14.4% | 9.3% |
Record order book masks margin compression; execution test ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit revenue growth (27.4% vs 18–20%), maintained EBITDA margin guidance. Delayed Kandla facility (Dec-Jan → March 2027).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Record ₹2,268 Cr order book and bullish space/cryo outlook are genuine, but Q2 margin compression (21.3% vs. 21–24% guidance band) and weak 9.4% PAT growth reveal execution stress. Kandla delay (March vs. Dec-Jan) signals capability constraints. Execution risk on ₹2,268 Cr backlog is the key near-term overhang.
₹456.5 Cr
Revenue · +27.4% YoY₹66.6 Cr
Reported PAT · +9.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Order book crossed ₹2,200 Cr, highest in history
METOrder book ₹2,268 Cr at Sept 30, 2026, confirmed in call
27.4% YoY revenue growth beats 18–20% FY27 guidance
METQ2 revenue ₹456.5 Cr, +27.4% YoY; guidance met and exceeded
EBITDA margin 21.3% for Q2 is within 21–24% range
METQ2 EBITDA margin 21.3%, H1 22.3% — lower end but within band
PAT growth 9.4% YoY indicates strong profitability
OVERSTATEDPAT ₹66.6 Cr, +9.4% YoY, but margin compression is real concern
Kandla facility commissioned by Dec 2026–Jan 2027
MISSMD said 'March of this year' [2027]; delayed by 2–3 months
Earnings quality
What changed since the last call
Order book doubled
UpgradeOrder book ₹2,268 Cr (Sept 2026) vs. ~₹1,000 Cr implied from prior year; driven by mega U.S. space order and domestic industrial gas
Kandla timeline slipped
DowngradePrior: Dec 2026–Jan 2027. Now: March 2027. MD cited construction ongoing; 2–3 month delay signals execution pressure
Margin compression acknowledged
DowngradeQ2 EBITDA margin 21.3% vs. historical 21–24% band mid-point; freight cost and strategic pricing for large orders cited as structural headwinds
New verticals gaining momentum
UpgradeCryo-Scientific ₹35 Cr (LIGO), ₹12 Cr (European); Semiconductor entry with Tata Electronics; Beverage keg +446% YoY; opens high-margin growth vectors
Space sector de-risked
Upgrade₹1,100 Cr space order book + confirmed U.S. customer 3–4 launch pad commercialisation by FY28; ISRO orders materialising (4 LNG rail orders dispatched 2)
The Q&A
Q&A was highly engaged. Analysts pressed hard on margin compression (Mohit Surana, Vinil Shah), ISRO order sizing (Eshwar), and execution risk on ₹2,268 Cr backlog (Bhavika Singhvi, Abhinav Nalawade). Management held firm, acknowledged freight/geo headwinds, reaffirmed 21–24% margin band going forward (though cautiously). No evasion detected; Deepak Acharya provided granular detail on segment margins, customer mix, and facility capacity.
EBITDA margin recovery — Mohit Surana, Monarch Network
PartialMix of rate pressure, freight, geopolitical challenges. H1 EBITDA margin 22.3% within guidance. Margins will improve; some aggressive pricing for strategic orders this quarter.
Space order execution — Eshwar, iThought PMS
Answered10–15% FY27, balance spills to FY28. Balance ~80–90% will be done next financial year. No RFQ specifics on spaceport yet.
LNG semi-trailer orders — Eshwar, iThought PMS
AnsweredYes, we are on track for yearly targets. 5 approvals received out of 5 major breweries. Market visibility improving.
Margin drivers by segment — Vinil Shah, Dalal & Broacha
AnsweredStandard equipment faces global competition, low margins. Non-standard (custom) equipment commands 21–24% margins. Strategic orders this quarter are exceptions; margins will improve as order book executes.
Order backlog composition — Vinil Shah, Dalal & Broacha
AnsweredApproximately correct. Balance is custom-built products. Execution focus is on complex and bigger projects.
Cryo-Scientific order timing — Bhavika Singhvi, Niveshay
AnsweredComplex equipment for heavy payload satellites; margins better vs. standard. Freight cost is in customer scope (Ex-works delivery). No cost headwind for us.
Subcoolers for U.S. aerospace — Bhavika Singhvi, Niveshay
Answered60–70% of space backlog is subcoolers. Nearly 16 subcooler orders (12 LOX, 4 methane). Critical project for us.
Semiconductor opportunity sizing — Vinil Shah, Dalal & Broacha
Partial₹1.6 lakh crore govt. approved projects ongoing; 70% in Gujarat (Dholera, Sanand). Early stage, small orders. 70% projects happening in Gujarat, so good service opportunity. Results in 4–6 weeks.
ISRO launch vehicle order — Abhinav Nalawade, ICICI Securities
AnsweredISRO size publicly known: ₹3,850 Cr launch pad. Bid received; tender likely 2–3 weeks away; results in 4–6 weeks. Very positive on Andaman Nicobar tender; already bid Indonesia projects.
Data center cooling demand — Avradhoot Joshi, Trivantage Capital
Answered100% uninterrupted power required for data centers. Products ready; entering area now. U.S. capex looks huge (50–300 megawatts). Trying to enter this market.
Order backlog export mix — Avradhoot Joshi, Trivantage Capital
Answered~60% exports. Almost 50% is to 2–3 major customers (U.S. aerospace + others). Back-to-back agreements for pricing.
Large order pricing strategy — Bharat Sheth, Quest Investment
AnsweredDebt-free, strong cash (₹384 Cr). Funding not constraint. Major bottleneck: skilled manpower, capacity at Savli. Kandla facility (March 2027) will ease pressure. Automation: 60–70% of welding/fabrication already automated.
Private space sector opportunity — Vandika, B.K. Shah
PartialTop 5 startup players in India; delivered to ~4 of them (small quantities). Private sector orders: ₹2,000–₹3,000 Cr total together with govt. (ISRO). 3–5 years, possibly ₹2,000–₹3,000 Cr from private players.
Launch vehicle (LVM3) bidding — Pravesh Kochar, FourLion Capital
AnsweredISRO site visit completed. Explained capabilities. INOX qualified technically now. Other players have money/capex; we have cryo expertise edge. Chance decent on bidding.
Microfactory partnership (Wayou) — Mohit Chugh, Subh Labh Research
AnsweredYes. Wayou (Swedish) dealing with microfactories (20-ft containers for water treatment). Started manufacturing at Savli. Scientists from Wayou present. Good growth prospects.
Guidance
FY27 revenue growth 18–20% minimum reaffirmed
HighQ2 delivered +27.4% YoY; order backlog ₹2,268 Cr provides 2–3 year visibility; CEO states 'growth at 18–20% minimum' going forward even if large opportunities don't land
EBITDA margin 21–24% range maintained
MediumQ2 came in at 21.3% (lower end); H1 22.3%. Management expects margin recovery in H2 as freight/geopolitical headwinds ease; 'some aggressive pricing this quarter' is temporary
Kandla facility by March 2027 (delayed from Dec 2026–Jan 2027)
MediumConstruction ongoing; 50% capacity expansion. Timing slip of 2–3 months signals execution pressure. No other major capex constraints cited; debt-free, ₹384 Cr cash available
Risks the call surfaced
Customer concentration
HighU.S. aerospace customer represents 60–70% of ₹1,100 Cr space backlog; ~50% of total ₹2,268 Cr backlog from 2–3 customers. Program delay or cancellation is material.
Execution capacity
MediumOrder backlog ₹2,268 Cr vs. historical annual revenue ~₹400–₹450 Cr; 2–3 year visibility. Kandla facility delayed (March vs. Dec-Jan); skilled labor shortage cited; automation at 60–70%.
Margin compression
MediumQ2 EBITDA margin 21.3% vs. historical 21–24% band; freight costs and geopolitical uncertainty cited. PAT growth only 9.4% YoY despite 27.4% revenue growth; indicates structural margin pressure.
Facility commissioning delay
MediumKandla facility targeted for March 2027 (previously Dec 2026–Jan 2027); 2–3 month slip. Current Savli capacity stretched; further order inflows may face production constraints in Q3–Q4 FY27.
New market adoption risk
LowSemicond. fab entry (Tata Electronics pilot), data center cooling, LIGO project all early-stage with uncertain ramp. Govt. fab tender delays could push semiconductor contribution to FY28+.
Management
Score 8/10. Transparent, detailed Q&A responses. Management (CEO Deepak Acharya, CFO Pavan Logar) provided granular breakdowns of margin drivers, order composition, segment dynamics, and execution roadmap. Acknowledged near-term headwinds (freight, geopolitics) without defensive tone. Track record strong: hit FY27 revenue growth target (27.4% vs. 18–20%). Maintained EBITDA margin guidance. Kandla delay is a miss (Dec-Jan → March, 2–3 months), but minor in context. Historical execution on complex aerospace/space orders is credible.
1 · Mar 2027
Kandla facility commissioning; expected to ease capacity constraints
2 · Q3–Q4 FY27
ISRO order execution; semi-trailer LNG, space tank deliveries
3 · FY28
U.S. space customer 3–4 launch pads commercialised; order scaling
Execution risk on ₹2,268 Cr backlog is the key near-term overhang.
Record backlog masks the execution test ahead
Revenue growth crushed guidance at 27.4%, but profit growth lagged at just 9.4% — margin compression from freight and strategic pricing reveals the real pressure. An ₹2,268 crore order backlog is genuine, but execution risk is the near-term overhang.
₹456.5 Cr
+27.4% YoY; beat 18–20% FY27 guidance
₹66.6 Cr
+9.4% YoY; growth lags revenue by 3x
21.3%
–110 bps YoY; within 21–24% band but lower end
₹2,268 Cr
All-time high; 5+ year revenue visibility
INOX reported a headline beat on revenue — ₹456.5 crore, up 27.4% year-on-year, well above the 18–20% FY27 guidance range. But profit growth tells a different story. Net profit ₹66.6 crore was up only 9.4% YoY. The gap between revenue acceleration and profit deceleration is the quarter's defining tension. EBITDA margin fell to 21.3% in Q2, down 110 basis points, pulling the half-year margin to 22.3% — within guidance but at the lower bound. Management attributed this to freight costs and geopolitical uncertainty. But the call revealed a second, structural driver: strategic pricing on large orders to win the ₹1,100 crore space backlog from a U.S. aerospace customer. That's not temporary. It's a margin trade-off for scale, and it signals execution pressure is real.
The order book did double — but concentration is the catch
The headline from the call is the order backlog: ₹2,268 crore, an all-time high. This is genuinely impressive — 5+ years of revenue visibility at current run rates. But three facts temper enthusiasm. First, ~60–70% of the ₹1,100 crore space backlog is from a single U.S. aerospace customer. Management confirmed 10–15% execution in FY27, with 80–90% spilling to FY28. A program delay or cancellation is material risk. Second, roughly 50% of total backlog comes from 2–3 customers, all aerospace or defence-linked. Third, current capacity is stretched. Savli is near full utilisation. Kandla, the 50%-capacity expansion site, was originally due December 2026–January 2027. It's now March 2027 — a 2–3 month slip that signals execution pressure. Tighter-than-implied execution runway for H2 FY27.
What changed on this call
Order book doubled to ₹2,268 Cr; space sector ₹1,100 Cr confirmed (structural upgrade)
Kandla facility delayed from Dec-Jan to March 2027 (execution warning)
Margin compression now partly structural via strategic pricing, not just freight (recalibration)
Space customer 3–4 launch pads to commercialise by FY28; ISRO tenders live (de-risking)
New verticals scaling: Cryo-Scientific ₹35 Cr LIGO, semiconductors, beverage keg +446% YoY
How the street sees it
The stock stands at ₹1,870.2 (as of Nov 6), down 20% from its all-time high of ₹2,339.5 and trading below both the 20-day (₹1,950) and 50-day (₹2,053) moving averages. RSI sits at 41.6, neutral. This drawdown reflects the market's re-pricing of execution risk. Foreign institutional ownership is stable at 6.87%, down 0.26 percentage points this quarter — not active selling, but notably flat. Domestic institutions hold 7.67%, effectively unchanged. Promoters remain at 74.86%. The absence of large insider selling near the all-time high is a small positive. But price action signals the market is waiting to see whether H2 FY27 execution validates the backlog or signals further delays. Until Kandla is live and space execution is clarified quarter-by-quarter, uncertainty will cap the stock near current levels.
Customer concentration: 60–70% of space backlog from one U.S. aerospace customer; ~50% of total from 2–3 customers
HighProgram delay or cancellation would materially impact FY28 revenue and profitability. Diversification to ISRO and private space underway but early.
Execution capacity constrained: ₹2,268 Cr backlog vs. ~₹450 Cr annual revenue; skilled labour scarcity; Kandla delayed
HighTight capacity forced 'strategic pricing' on large orders; if execution slips further, Q3–Q4 margins compress or delivery delays trigger penalties.
Margin recovery timing uncertain: management expects H2 improvement as freight/geo headwinds ease, but structural pricing remains
MediumIf margins don't recover to 21–24% by Q3, confidence in FY28 profit growth erodes. PAT growth already lags revenue at 9.4% YoY.
Kandla commissioning delay (Dec-Jan → March 2027) signals execution pressure and constrains H2 capacity if orders accelerate
MediumA further slip beyond March would force subcontracting or delivery delays, both margin headwinds or reputation risks.
New market scaling: Semiconductors, data centers early-stage; tender delays could push contributions to FY28+
LowCurrently small; upside optionality rather than near-term risk.
The bull-bear ledger
Record ₹2,268 Cr order backlog provides 5+ year visibility; space sector validated
Space customer 3–4 launch pads to commercialise by FY28; ISRO tenders live; structural tailwind
Debt-free ₹384 Cr net cash; no funding constraints for Kandla or capex
New verticals (LIGO ₹35 Cr, semiconductors, data centers) opening high-margin vectors
Revenue +27.4% crushes 18–20% guidance; execution has delivered to date
PAT +9.4% lags revenue; margin compression is structural, not one-time
EBITDA margin 21.3% at lower end of band; H1 22.3% still below historical 22–24% mid-point
Customer concentration: 60–70% of space backlog from one customer; ~50% of total from 2–3 customers
Kandla delayed; execution pressure evident in timeline slip and current capacity utilisation
1 · Kandla commissioning (March 2027)
On time delivery validates management credibility. Further delay signals execution is more constrained than portrayed. March 2027 is the credibility test.
2 · Space order execution pace (Q3–Q4 FY27)
10–15% of U.S. aerospace backlog in FY27, balance FY28. If orders slip or Q4 execution is weak, 2–3 year visibility becomes uncertain. Watch quarterly sequencing.
3 · EBITDA margin trend (H2 FY27)
Will margins recover to 22–24% or stabilise at 21–22%? This settles whether the 9.4% PAT growth gap vs. revenue is temporary or structural. Q3 print is decisive.
4 · ISRO and semiconductor tenders (Q3–Q4)
ISRO launch pad tender expected 2–3 weeks post-call, results in 4–6 weeks. Semiconductor fab projects in Gujarat; award sizing will signal diversification progress beyond aerospace.
The verdict
INOX has delivered a genuine beat on revenue growth. The ₹2,268 crore order backlog is real, and management is executing — Kandla is coming, ISRO tenders are live, new verticals are gaining traction. But this quarter exposed the pressure: executing on that backlog requires margin compression today, skilled labour shortages that the market hasn't resolved, and capex timelines that are slipping. The stock's 20% drawdown from the all-time high is not irrational — it reflects the market's re-pricing of execution risk. Holders are waiting to see whether H2 FY27 execution validates 18–20% growth and the margin band, or forces guidance revision downward. Until Kandla is live and U.S. aerospace 10–15% FY27 allocation is clarified sequentially, execution uncertainty will cap the stock near current levels. The rating is Hold on execution risk. The single metric to track is EBITDA margin trend. If Q3 comes in at 21.5%+ and H2 shows no Kandla slips, the case for re-rating up gains traction. Below 21%, margin guidance is in play and the backlog story becomes less attractive.